| __timestamp | Celldex Therapeutics, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 406114000 |
| Thursday, January 1, 2015 | 33837000 | 449119000 |
| Friday, January 1, 2016 | 35979000 | 502892000 |
| Sunday, January 1, 2017 | 25003000 | 544156000 |
| Monday, January 1, 2018 | 19269000 | 683530000 |
| Tuesday, January 1, 2019 | 15426000 | 736942000 |
| Wednesday, January 1, 2020 | 14456000 | 854233000 |
| Friday, January 1, 2021 | 20488000 | 1451683000 |
| Saturday, January 1, 2022 | 27195000 | 1416967000 |
| Sunday, January 1, 2023 | 30914000 | 1343105000 |
In pursuit of knowledge
In the competitive landscape of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for operational efficiency. Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc. offer a fascinating study in contrasts from 2014 to 2023. Jazz Pharmaceuticals consistently outpaced Celldex, with SG&A expenses peaking at approximately $1.45 billion in 2021, a staggering 4,600% higher than Celldex's peak of $36 million in 2016. This disparity highlights Jazz's expansive operations and market reach. However, Celldex's more modest SG&A growth, averaging around $24 million annually, suggests a leaner approach, potentially allowing for more agile innovation. As the industry evolves, these trends underscore the strategic choices companies make in balancing growth with cost efficiency. Understanding these dynamics is essential for investors and stakeholders aiming to navigate the biopharma sector's complexities.
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Celldex Therapeutics, Inc.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Cytokinetics, Incorporated or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights